National Health Act 1953 Amendment determination under section 85B price determinations and special patient contributions (No. PB 65 of 2009) (Cth)

COMMONWEALTH OF AUSTRALIA

Instrument number PB 65 of 2009

Amendment determination under section 85B of the National Health Act 1953

I, LINDA JACKSON, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under section 85B of the National Health Act 1953.

Dated 6 July 2009

LINDA JACKSON

Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Amendment — price determinations and special patient contributions

1              Commencement  

This instrument commences on 1 August 2009.

2              Amendment of PB 118 of 2008

Schedule 1 amends PB 118 of 2008.

Schedule 1        Amendments

[1]         Schedule 1, item dealing with Alendronic Acid

(a) omit from the column headed “Determined Price”:

36.38

and substitute:

35.65

(b) omit from the column headed “Claimed Price”:

37.80

and substitute:

37.04

[2]         Schedule 1, item dealing with Amlodipine in the form Tablet 5 mg (as besylate)

(a) omit from the column headed “Determined Price”:

9.10

and substitute:

8.92

(b) omit from the column headed “Claimed Price”:

12.50

and substitute:

12.32

[3]         Schedule 1, item dealing with Amlodipine in the form Tablet 10 mg (as besylate)

(a) omit from the column headed “Determined Price”:

16.01

and substitute:

15.63

(b) omit from the column headed “Claimed Price”:

20.95

and substitute:

20.57

[4]         Schedule 1, item dealing with Aspirin

(a) omit from the column headed “Determined Price”:

1.49

and substitute:

1.46

(b) omit from the column headed “Claimed Price”:

2.67

and substitute:

2.62

[5]         Schedule 1, item dealing with Betamethasone in the form Cream 200 micrograms (as valerate) per g, 100 g

(a) omit from the column headed “Determined Price”:

8.22

and substitute:

8.06

(b) omit from the column headed “Claimed Price”:

10.90

and substitute:

10.68

[6]         Schedule 1, item dealing with Betamethasone in the form Cream 500 micrograms (as valerate) per g, 15 g

(a) omit from the column headed “Determined Price”:

1.85

and substitute:

1.81

(b) omit from the column headed “Claimed Price”:

3.51

and substitute:

3.44

[7]         Schedule 1, item dealing with Betamethasone in the form Ointment 500 micrograms (as valerate) per g, 15 g

(a) omit from the column headed “Determined Price”:

1.85

and substitute:

1.81

(b) omit from the column headed “Claimed Price”:

3.51

and substitute:

3.44

[8]         Schedule 1, item dealing with Betaxolol

(a) omit from the column headed “Determined Price”:

7.71

and substitute:

7.56

(b) omit from the column headed “Claimed Price”:

9.61

and substitute:

9.42

[9]         Schedule 1, item dealing with Bisacodyl

(a) omit from the column headed “Determined Price”:

4.48

and substitute:

4.39

(b) omit from the column headed “Claimed Price”:

4.81

and substitute:

4.71

[10]       Schedule 1, item dealing with Bleomycin (Blenamax)

(a) omit from the column headed “Determined Price”:

467.10

and substitute:

457.76

(b) omit from the column headed “Claimed Price”:

887.30

and substitute:

869.55

[11]       Schedule 1, item dealing with Bleomycin (Blenoxane)

(a) omit from the column headed “Determined Price”:

467.10

and substitute:

457.76

(b) omit from the column headed “Claimed Price”:

959.70

and substitute:

940.51

[12]       Schedule 1, item dealing with Bleomycin (Hospira Pty Limited)

(a) omit from the column headed “Determined Price”:

46.71

and substitute:

45.78

(b) omit from the column headed “Claimed Price”:

88.73

and substitute:

86.96

[13]       Schedule 1, item dealing with Brimonidine

(a) omit from the column headed “Determined Price”:

12.67

and substitute:

12.42

(b) omit from the column headed “Claimed Price”:

14.18

and substitute:

13.90

[14]       Schedule 1, item dealing with Brinzolamide

(a) omit from the column headed “Determined Price”:

15.11

and substitute:

14.81

(b) omit from the column headed “Claimed Price”:

16.18

and substitute:

15.86

[15]       Schedule 1, item dealing with Bupropion

(a) omit from the column headed “Determined Price”:

64.40

and substitute:

63.11

(b) omit from the column headed “Claimed Price”:

65.17

and substitute:

63.87

(c) omit from the column headed “Determined Price”:

147.37

and substitute:

144.42

(d) omit from the column headed “Claimed Price”:

148.15

and substitute:

145.19

[16]       Schedule 1, item dealing with Carbomer

(a) omit from the column headed “Determined Price”:

3.56

and substitute:

3.49

(b) omit from the column headed “Claimed Price”:

4.43

and substitute:

4.34

[17]       Schedule 1, item dealing with Cefotaxime in the form Powder for injection 1 g (as sodium)

(a) omit from the column headed “Determined Price”:

1.85

and substitute:

1.81

(b) omit from the column headed “Claimed Price”:

4.19

and substitute:

4.11

[18]       Schedule 1, item dealing with Cefotaxime in the form Powder for injection 2 g (as sodium)

(a) omit from the column headed “Determined Price”:

3.41

and substitute:

3.34

(b) omit from the column headed “Claimed Price”:

7.74

and substitute:

7.59

[19]       Schedule 1, item dealing with Clindamycin

(a) omit from the column headed “Determined Price”:

12.32

and substitute:

12.07

(b) omit from the column headed “Claimed Price”:

13.58

and substitute:

13.31

[20]       Schedule 1, item dealing with Clomiphene

omit from the column headed “Claimed Price”:

23.32

and substitute:

26.59

[21]       Schedule 1, item dealing with Colchicine

(a) omit from the column headed “Determined Price”:

4.28

and substitute:

4.19

(b) omit from the column headed “Claimed Price”:

5.07

and substitute:

4.97

[22]       Schedule 1, item dealing with Cyclosporin in the form Capsule 25 mg

(a) omit from the column headed “Determined Price”:

43.86

and substitute:

42.98

(b) omit from the column headed “Claimed Price”:

44.90

and substitute:

44.00

[23]       Schedule 1, item dealing with Cyclosporin in the form Capsule 50 mg

(a) omit from the column headed “Determined Price”:

91.26

and substitute:

89.43

(b) omit from the column headed “Claimed Price”:

92.38

and substitute:

90.53

[24]       Schedule 1, item dealing with Cyclosporin in the form Capsule 100 mg

(a) omit from the column headed “Determined Price”:

185.94

and substitute:

182.22

(b) omit from the column headed “Claimed Price”:

187.07

and substitute:

183.33

[25]       Schedule 1, item dealing with Dexamethasone with Framycetin and Gramicidin

(a) omit from the column headed “Determined Price”:

2.73

and substitute:

2.68

(b) omit from the column headed “Claimed Price”:

4.47

and substitute:

4.38

[26]       Schedule 1, item dealing with Digoxin in the form Tablet 62.5 micrograms

(a) omit from the column headed “Determined Price”:

3.69

and substitute:

3.62

(b) omit from the column headed “Claimed Price”:

5.24

and substitute:

5.14

[27]       Schedule 1, item dealing with Digoxin in the form Tablet 250 micrograms

(a) omit from the column headed “Determined Price”:

3.97

and substitute:

3.89

(b) omit from the column headed “Claimed Price”:

5.54

and substitute:

5.43

[28]       Schedule 1, item dealing with Diphenoxylate with Atropine

(a) omit from the column headed “Determined Price”:

1.91

and substitute:

1.87

(b) omit from the column headed “Claimed Price”:

3.50

and substitute:

3.43

[29]       Schedule 1, item dealing with Escitalopram in the form Tablet 10 mg (as oxalate)

(a) omit from the column headed “Determined Price”:

19.99

and substitute:

19.59

(b) omit from the column headed “Claimed Price”:

24.24

and substitute:

23.76

[30]       Schedule 1, item dealing with Escitalopram in the form Tablet 20 mg (as oxalate)

(a) omit from the column headed “Determined Price”:

20.11

and substitute:

19.71

(b) omit from the column headed “Claimed Price”:

26.34

and substitute:

25.81

[31]       Schedule 1, item dealing with Felodipine in the form Tablet 2.5 mg (extended release)

(a) omit from the column headed “Determined Price”:

6.14

and substitute:

6.09

(b) omit from the column headed “Claimed Price”:

10.49

and substitute:

10.43

[32]       Schedule 1, item dealing with Felodipine in the form Tablet 5 mg (extended release)

(a) omit from the column headed “Determined Price”:

8.45

and substitute:

8.37

(b) omit from the column headed “Claimed Price”:

12.80

and substitute:

12.72

[33]       Schedule 1, item dealing with Felodipine in the form Tablet 10 mg (extended release)

(a) omit from the column headed “Determined Price”:

15.12

and substitute:

15.00

(b) omit from the column headed “Claimed Price”:

19.47

and substitute:

19.35

[34]       Schedule 1, item dealing with Fluvastatin in the form Capsule 20 mg (as sodium) (first instance)

(a) omit from the column headed “Determined Price”:

17.59

and substitute:

17.24

(b) omit from the column headed “Claimed Price”:

20.44

and substitute:

20.03

[35]         Schedule 1, item dealing with Fluvastatin in the form Capsule 20 mg (as sodium) (second instance)

omit from the columns in the order indicated:

Oral Vastin 28 17.59 19.02

[36]       Schedule 1, item dealing with Fluvastatin in the form Capsule 40 mg (as sodium) (first instance)

(a) omit from the column headed “Determined Price”:

21.56

and substitute:

21.13

(b) omit from the column headed “Claimed Price”:

23.11

and substitute:

24.18

[37]         Schedule 1, item dealing with Fluvastatin in the form Capsule 40 mg (as sodium) (second instance)

omit from the columns in the order indicated:

Oral Vastin 28 21.56 24.67

[38]       Schedule 1, item dealing with Glibenclamide

(a) omit from the column headed “Determined Price”:

4.59

and substitute:

4.50

(b) omit from the column headed “Claimed Price”:

5.90

and substitute:

5.78

[39]       Schedule 1, item dealing with Glipizide

(a) omit from the column headed “Determined Price”:

4.67

and substitute:

4.58

(b) omit from the column headed “Claimed Price”:

8.21

and substitute:

8.05

[40]       Schedule 1, item dealing with Glyceryl Trinitrate

(a) omit from the column headed “Determined Price”:

5.19

and substitute:

5.09

(b) omit from the column headed “Claimed Price”:

6.62

and substitute:

6.49

[41]       Schedule 1, item dealing with Hydrocortisone in the form Cream containing hydrocortisone acetate 10 mg per g,

30 g

(a) omit from the column headed “Determined Price”:

2.28

and substitute:

2.23

(b) omit from the column headed “Claimed Price”:

3.93

and substitute:

3.85

[42]       Schedule 1, item dealing with Hydrocortisone in the form Cream containing hydrocortisone acetate 10 mg per g,

50 g (Cortef)

(a) omit from the column headed “Determined Price”:

1.98

and substitute:

1.94

(b) omit from the column headed “Claimed Price”:

2.05

and substitute:

2.01

[43]       Schedule 1, item dealing with Hydrocortisone in the form Cream containing hydrocortisone acetate 10 mg per g,

50 g (Sigmacort)

(a) omit from the column headed “Determined Price”:

1.98

and substitute:

1.94

(b) omit from the column headed “Claimed Price”:

3.64

and substitute:

3.57

[44]       Schedule 1, item dealing with Hydrocortisone in the form Ointment containing hydrocortisone acetate 10 mg per g,

30 g

(a) omit from the column headed “Determined Price”:

2.28

and substitute:

2.23

(b) omit from the column headed “Claimed Price”:

3.93

and substitute:

3.85

[45]       Schedule 1, item dealing with Hydrocortisone in the form Ointment containing hydrocortisone acetate 10 mg per g,

50 g

(a) omit from the column headed “Determined Price”:

1.98

and substitute:

1.94

(b) omit from the column headed “Claimed Price”:

3.64

and substitute:

3.57

[46]       Schedule 1, item dealing with Hypromellose

(a) omit from the column headed “Determined Price”:

3.56

and substitute:

3.49

(b) omit from the column headed “Claimed Price”:

5.17

and substitute:

5.07

[47]       Schedule 1, item dealing with Hypromellose with Carbomer 980

(a) omit from the column headed “Determined Price”:

3.56

and substitute:

3.49

(b) omit from the column headed “Claimed Price”:

5.17

and substitute:

5.07

[48]       Schedule 1, item dealing with Hypromellose with Dextran

(a) omit from the column headed “Determined Price”:

3.75

and substitute:

3.68

(b) omit from the column headed “Claimed Price”:

5.37

and substitute:

5.26

[49]       Schedule 1, item dealing with Imipramine in both forms

(a) omit from the column headed “Determined Price”:

1.96

and substitute:

1.92

(b) omit from the column headed “Claimed Price”:

4.54

and substitute:

4.45

[50]       Schedule 1, item dealing with Indomethacin

omit from the column headed “Claimed Price”:

2.86

and substitute:

3.40

[51]       Schedule 1, item dealing with Isotretinoin

(a) omit from the column headed “Determined Price”:

124.88

and substitute:

122.38

(b) omit from the column headed “Claimed Price”:

127.04

and substitute:

124.50

[52]      Schedule 1, item dealing with Ketoprofen

(a) omit from the column headed “Determined Price”:

11.72

and substitute:

11.49

(b) omit from the column headed “Claimed Price”:

13.72

and substitute:

13.45

[53]       Schedule 1, item dealing with Labetalol in the form Tablet containing labetalol hydrochloride 100 mg

(a) omit from the column headed “Determined Price”:

8.18

and substitute:

8.02

(b) omit from the column headed “Claimed Price”:

10.78

and substitute:

10.56

[54]       Schedule 1, item dealing with Labetalol in the form Tablet containing labetalol hydrochloride 200 mg

(a) omit from the column headed “Determined Price”:

13.47

and substitute:

13.20

(b) omit from the column headed “Claimed Price”:

16.05

and substitute:

15.73

[55]       Schedule 1, item dealing with Lercanidipine in the form Tablet containing lercanidipine hydrochloride 10 mg

omit from the column headed “Determined Price”:

12.21

and substitute:

11.64

[56]       Schedule 1, item dealing with Lercanidipine in the form Tablet containing lercanidipine hydrochloride 20 mg

omit from the column headed “Determined Price”:

20.03

and substitute:

19.47

[57]       Schedule 1, item dealing with Levodopa with Carbidopa in the form Tablet 100 mg-25 mg (anhydrous)

(a) omit from the column headed “Determined Price”:

29.45

and substitute:

28.86

(b) omit from the column headed “Claimed Price”:

34.59

and substitute:

33.90

[58]       Schedule 1, item dealing with Levodopa with Carbidopa in the form Tablet 250 mg-25 mg (anhydrous)

(a) omit from the column headed “Determined Price”:

36.31

and substitute:

35.58

(b) omit from the column headed “Claimed Price”:

39.41

and substitute:

38.62

[59]       Schedule 1, item dealing with Levonorgestrel with Ethinyloestradiol in the form Tablets 150 micrograms-30 micrograms, 21

(a) omit from the column headed “Determined Price”:

9.77

and substitute:

9.57

(b) omit from the column headed “Claimed Price”:

20.81

and substitute:

20.39

[60]       Schedule 1, item dealing with Levonorgestrel with Ethinyloestradiol in the form Pack containing 21 tablets

150 micrograms-30 micrograms and 7 inert tablets (Nordette 28)

(a) omit from the column headed “Determined Price”:

9.77

and substitute:

9.57

(b) omit from the column headed “Claimed Price”:

20.43

and substitute:

20.02

[61]       Schedule 1, item dealing with Levonorgestrel with Ethinyloestradiol in the form Pack containing 21 tablets

150 micrograms-30 micrograms and 7 inert tablets (Microgynon 30 ED)

(a) omit from the column headed “Determined Price”:

9.77

and substitute:

9.57

(b) omit from the column headed “Claimed Price”:

20.81

and substitute:

20.39

[62]       Schedule 1, item dealing with Levonorgestrel with Ethinyloestradiol in the form Pack containing 6 tablets

50 micrograms-30 micrograms, 5 tablets 75 micrograms-40 micrograms, 10 tablets 125 micrograms-

30 micrograms and 7 inert tablets (Triphasil 28)

(a) omit from the column headed “Determined Price”:

9.77

and substitute:

9.57

(b) omit from the column headed “Claimed Price”:

20.43

and substitute:

20.02

[63]       Schedule 1, item dealing with Levonorgestrel with Ethinyloestradiol in the form Pack containing 6 tablets

50 micrograms-30 micrograms, 5 tablets 75 micrograms-40 micrograms, 10 tablets 125 micrograms-

30 micrograms and 7 inert tablets (Triquilar ED)

(a) omit from the column headed “Determined Price”:

9.77

and substitute:

9.57

(b) omit from the column headed “Claimed Price”:

20.81

and substitute:

20.39

[64]       Schedule 1, item dealing with Loperamide

(a) omit from the column headed “Determined Price”:

1.89

and substitute:

1.85

(b) omit from the column headed “Claimed Price”:

2.70

and substitute:

2.65

[65]       Schedule 1, item dealing with Medroxyprogesterone in the form Tablet containing medroxyprogesterone acetate

5 mg

(a) omit from the column headed “Determined Price”:

7.64

and substitute:

7.49

(b) omit from the column headed “Claimed Price”:

9.16

and substitute:

8.98

[66]       Schedule 1, item dealing with Medroxyprogesterone in the form Tablet containing medroxyprogesterone acetate

10 mg

(a) omit from the column headed “Determined Price”:

8.20

and substitute:

8.04

(b) omit from the column headed “Claimed Price”:

9.72

and substitute:

9.53

(c) omit from the column headed “Determined Price”:

22.43

and substitute:

21.98

(d) omit from the column headed “Claimed Price”:

23.85

and substitute:

23.37

[67]       Schedule 1, item dealing with Medroxyprogesterone in the form Injection containing medroxyprogesterone acetate

150 mg in 1 mL

(a) omit from the column headed “Determined Price”:

7.15

and substitute:

7.01

(b) omit from the column headed “Claimed Price”:

10.05

and substitute:

9.85

[68]       Schedule 1, item dealing with Meloxicam in the form Tablet 7.5 mg

(a) omit from the column headed “Determined Price”:

13.64

and substitute:

13.37

(b) omit from the column headed “Claimed Price”:

15.04

and substitute:

14.74

[69]       Schedule 1, item dealing with Meloxicam in the form Tablet 15 mg

(a) omit from the column headed “Determined Price”:

19.89

and substitute:

19.49

(b) omit from the column headed “Claimed Price”:

21.30

and substitute:

20.87

[70]       Schedule 1, item dealing with Methyldopa

(a) omit from the column headed “Determined Price”:

5.39

and substitute:

6.29

(b) omit from the column headed “Claimed Price”:

7.34

and substitute:

8.59

[71]       Schedule 1, item dealing with Methylprednisolone

(a) omit from the column headed “Determined Price”:

16.46

and substitute:

16.13

(b) omit from the column headed “Claimed Price”:

17.12

and substitute:

16.78

[72]       Schedule 1, item dealing with Mianserin in the form Tablet containing mianserin hydrochloride 10 mg

(a) omit from the column headed “Determined Price”:

8.28

and substitute:

8.11

(b) omit from the column headed “Claimed Price”:

10.01

and substitute:

9.81

[73]       Schedule 1, item dealing with Mianserin in the form Tablet containing mianserin hydrochloride 20 mg

(a) omit from the column headed “Determined Price”:

17.48

and substitute:

17.13

(b) omit from the column headed “Claimed Price”:

20.06

and substitute:

19.66

[74]       Schedule 1, item dealing with Norethisterone

(a) omit from the column headed “Determined Price”:

2.32

and substitute:

2.27

(b) omit from the column headed “Claimed Price”:

3.19

and substitute:

3.13

[75]       Schedule 1, item dealing with Norethisterone with Ethinyloestradiol in all five forms

(a) omit from the column headed “Determined Price”:

2.32

and substitute:

2.27

(b) omit from the column headed “Claimed Price”:

4.04

and substitute:

3.96

[76]       Schedule 1, item dealing with Omeprazole

omit from the column headed “Claimed Price”:

22.32

and substitute:

22.76

[77]       Schedule 1, item dealing with Ondansetron in the form Tablet 4 mg (as hydrochloride dihydrate)

(a) omit from the column headed “Determined Price”:

29.90

and substitute:

29.30

(b) omit from the column headed “Claimed Price”:

30.51

and substitute:

29.90

(c) omit from the column headed “Determined Price”:

74.73

and substitute:

73.24

(d) omit from the column headed “Claimed Price”:

75.35

and substitute:

73.84

[78]       Schedule 1, item dealing with Ondansetron in the form Tablet 8 mg (as hydrochloride dihydrate)

(a) omit from the column headed “Determined Price”:

46.83

and substitute:

45.89

(b) omit from the column headed “Claimed Price”:

47.45

and substitute:

46.50

(c) omit from the column headed “Determined Price”:

117.08

and substitute:

114.74

(d) omit from the column headed “Claimed Price”:

117.69

and substitute:

115.34

[79]       Schedule 1, item dealing with Ondansetron in the form Wafer 4 mg

(a) omit from the column headed “Determined Price”:

29.90

and substitute:

29.30

(b) omit from the column headed “Claimed Price”:

30.51

and substitute:

29.90

(c) omit from the column headed “Determined Price”:

74.73

and substitute:

73.24

(d) omit from the column headed “Claimed Price”:

75.35

and substitute:

73.84

[80]       Schedule 1, item dealing with Ondansetron in the form Wafer 8 mg

(a) omit from the column headed “Determined Price”:

46.83

and substitute:

45.89

(b) omit from the column headed “Claimed Price”:

47.45

and substitute:

46.50

(c) omit from the column headed “Determined Price”:

117.08

and substitute:

114.74

(d) omit from the column headed “Claimed Price”:

117.69

and substitute:

115.34

[81]       Schedule 1, item dealing with Ondansetron in the form I.V. injection 4 mg (as hydrochloride dihydrate) in 2 mL

(a) omit from the column headed “Determined Price”:

16.86

and substitute:

16.52

(b) omit from the column headed “Claimed Price”:

17.47

and substitute:

17.12

[82]       Schedule 1, item dealing with Ondansetron in the form I.V. injection 8 mg (as hydrochloride dihydrate) in 4 mL

(a) omit from the column headed “Determined Price”:

26.78

and substitute:

26.24

(b) omit from the column headed “Claimed Price”:

27.38

and substitute:

26.83

[83]       Schedule 1, item dealing with Oxazepam in the form Tablet 15 mg

(a) omit from the column headed “Determined Price”:

1.11

and substitute:

1.09

(b) omit from the column headed “Claimed Price”:

2.66

and substitute:

2.61

[84]       Schedule 1, item dealing with Oxazepam in the form Tablet 30 mg

(a) omit from the column headed “Determined Price”:

1.28

and substitute:

1.25

(b) omit from the column headed “Claimed Price”:

2.93

and substitute:

2.87

[85]       Schedule 1, item dealing with Paraffin in the form Eye ointment, compound, containing white soft paraffin with liquid paraffin, 3.5 g

(a) omit from the column headed “Determined Price”:

6.84

and substitute:

6.70

(b) omit from the column headed “Claimed Price”:

7.82

and substitute:

7.66

[86]       Schedule 1, item dealing with Paraffin in the form Pack containing 2 tubes eye ointment, compound, containing white soft paraffin with liquid paraffin, 3.5 g

(a) omit from the column headed “Determined Price”:

13.10

and substitute:

12.84

(b) omit from the column headed “Claimed Price”:

15.05

and substitute:

14.75

[87]       Schedule 1, item dealing with Polyvinyl Alcohol in the form Eye drops 14 mg per mL, 15 mL

(a) omit from the column headed “Determined Price”:

3.56

and substitute:

3.49

(b) omit from the column headed “Claimed Price”:

5.04

and substitute:

4.94

[88]       Schedule 1, item dealing with Polyvinyl Alcohol in the form Eye drops 30 mg per mL, 15 mL

(a) omit from the column headed “Determined Price”:

3.56

and substitute:

3.49

(b) omit from the column headed “Claimed Price”:

8.72

and substitute:

8.55

[89]       Schedule 1, item dealing with Potassium Chloride

(a) omit from the column headed “Determined Price”:

2.99

and substitute:

2.93

(b) omit from the column headed “Claimed Price”:

4.21

and substitute:

4.13

[90]       Schedule 1, item dealing with Potassium Chloride with Potassium Bicarbonate

(a) omit from the column headed “Determined Price”:

5.78

and substitute:

5.66

(b) omit from the column headed “Claimed Price”:

8.05

and substitute:

7.89

[91]       Schedule 1, item dealing with Prednisone

(a) omit from the column headed “Determined Price”:

2.24

and substitute:

2.20

(b) omit from the column headed “Claimed Price”:

2.81

and substitute:

2.75

[92]       Schedule 1, item dealing with Prochlorperazine

(a) omit from the column headed “Determined Price”:

3.13

and substitute:

3.07

(b) omit from the column headed “Claimed Price”:

5.30

and substitute:

5.19

[93]       Schedule 1, item dealing with Quinine

(a) omit from the column headed “Determined Price”:

5.24

and substitute:

5.14

(b) omit from the column headed “Claimed Price”:

7.13

and substitute:

6.99

[94]       Schedule 1, item dealing with Sucralfate

(a) omit from the column headed “Determined Price”:

15.64

and substitute:

15.33

(b) omit from the column headed “Claimed Price”:

17.54

and substitute:

17.19

[95]       Schedule 1, item dealing with Sulfasalazine

(a) omit from the column headed “Determined Price”:

23.01

and substitute:

22.55

(b) omit from the column headed “Claimed Price”:

23.74

and substitute:

23.27

[96]       Schedule 1, item dealing with Temazepam

(a) omit from the column headed “Determined Price”:

1.28

and substitute:

1.12

(b) omit from the column headed “Claimed Price”:

2.48

and substitute:

2.17

[97]       Schedule 1, item dealing with Thyroxine in the form Tablet containing 50 micrograms anhydrous thyroxine sodium

(a) omit from the column headed “Determined Price”:

15.66

and substitute:

15.35

(b) omit from the column headed “Claimed Price”:

16.79

and substitute:

16.45

[98]       Schedule 1, item dealing with Thyroxine in the form Tablet containing 75 micrograms anhydrous thyroxine sodium

(a) omit from the column headed “Determined Price”:

16.26

and substitute:

15.93

(b) omit from the column headed “Claimed Price”:

17.53

and substitute:

17.18

[99]       Schedule 1, item dealing with Thyroxine in the form Tablet containing 100 micrograms anhydrous

thyroxine sodium

(a) omit from the column headed “Determined Price”:

16.22

and substitute:

15.90

(b) omit from the column headed “Claimed Price”:

17.36

and substitute:

17.01

[100]     Schedule 1, item dealing with Thyroxine in the form Tablet containing 200 micrograms anhydrous

thyroxine sodium

(a) omit from the column headed “Determined Price”:

19.02

and substitute:

18.64

(b) omit from the column headed “Claimed Price”:

20.14

and substitute:

19.74

[101]     Schedule 1, item dealing with Tinidazole

(a) omit from the column headed “Determined Price”:

2.55

and substitute:

2.50

(b) omit from the column headed “Claimed Price”:

4.73

and substitute:

4.64

[102]     Schedule 1, item dealing with Triamcinolone in both forms

(a) omit from the column headed “Determined Price”:

3.68

and substitute:

3.61

(b) omit from the column headed “Claimed Price”:

5.11

and substitute:

5.01

[103]     Schedule 1, item dealing with Triamcinolone with Neomycin, Gramicidin and Nystatin in the form Ear drops containing triamcinolone acetonide 1 mg with neomycin 2.5 mg (as sulfate), gramicidin 250 micrograms and nystatin 100,000 units per g, 7.5 mL

(a) omit from the column headed “Determined Price”:

4.31

and substitute:

4.22

(b) omit from the column headed “Claimed Price”:

5.24

and substitute:

5.14

[104]     Schedule 1, item dealing with Triamcinolone with Neomycin, Gramicidin and Nystatin in the form Ear ointment containing triamcinolone acetonide 1 mg with neomycin 2.5 mg (as sulfate), gramicidin 250 micrograms and nystatin 100,000 units per g, 5 g

(a) omit from the column headed “Determined Price”:

1.62

and substitute:

1.59

(b) omit from the column headed “Claimed Price”:

2.56

and substitute:

2.51

[105]     Schedule 1, item dealing with Valproic Acid in the form Tablet (enteric coated) containing sodium valproate 200 mg

(a) omit from the column headed “Determined Price”:

11.93

and substitute:

11.69

(b) omit from the column headed “Claimed Price”:

12.58

and substitute:

12.33

[106]     Schedule 1, item dealing with Valproic Acid in the form Tablet (enteric coated) containing sodium valproate 500 mg

(a) omit from the column headed “Determined Price”:

23.62

and substitute:

23.15

(b) omit from the column headed “Claimed Price”:

24.30

and substitute:

23.81